Dexloxiglumide for the treatment of constipation predominant irritable bowel syndrome.
- Published in:
- Expert Opinion on Pharmacotherapy, 2016, v. 17, n. 14, p. 1969, doi. 10.1080/14656566.2016.1229306
- By:
- Publication type:
- Article
Works matching IS 1465-6566 AND VI 17 AND IP 14 AND DT 2016
Results: 15
1
2
Efficacy of trabectedin for the treatment of liposarcoma.
- Published in:
- Expert Opinion on Pharmacotherapy, 2016, v. 17, n. 14, p. 1953, doi. 10.1080/14656566.2016.1229304
- By:
- Publication type:
- Article
3
Emerging and future therapies for nonalcoholic steatohepatitis in adults.
- Published in:
- Expert Opinion on Pharmacotherapy, 2016, v. 17, n. 14, p. 1937, doi. 10.1080/14656566.2016.1225727
- By:
- Publication type:
- Article
4
Sonidegib for the treatment of advanced basal cell carcinoma.
- Published in:
- Expert Opinion on Pharmacotherapy, 2016, v. 17, n. 14, p. 1963, doi. 10.1080/14656566.2016.1225725
- By:
- Publication type:
- Article
5
Systemic treatment for advanced hepatocellular carcinoma: the search of new agents to join sorafenib in the effective therapeutic armamentarium.
- Published in:
- Expert Opinion on Pharmacotherapy, 2016, v. 17, n. 14, p. 1923, doi. 10.1080/14656566.2016.1225722
- By:
- Publication type:
- Article
6
Palbociclib and tumor suppressor gene activation.
- Published in:
- Expert Opinion on Pharmacotherapy, 2016, v. 17, n. 14, p. 1975, doi. 10.1080/14656566.2016.1222773
- By:
- Publication type:
- Article
7
Treatment of head and neck cancer in the elderly.
- Published in:
- Expert Opinion on Pharmacotherapy, 2016, v. 17, n. 14, p. 1903, doi. 10.1080/14656566.2016.1220540
- By:
- Publication type:
- Article
8
Statins worsen glycemic control of T2DM in target LDL-c level and LDL-c reduction dependent manners: a meta-analysis.
- Published in:
- Expert Opinion on Pharmacotherapy, 2016, v. 17, n. 14, p. 1839, doi. 10.1080/14656566.2016.1220539
- By:
- Publication type:
- Article
9
Treating hyperphosphatemia – current and advancing drugs.
- Published in:
- Expert Opinion on Pharmacotherapy, 2016, v. 17, n. 14, p. 1873, doi. 10.1080/14656566.2016.1220538
- By:
- Publication type:
- Article
10
Current pharmacotherapy of depression – focused on multimodal/multifunctional antidepressants.
- Published in:
- 2016
- By:
- Publication type:
- Editorial
11
An update on adjuvant systemic therapy for elderly patients with early breast cancer.
- Published in:
- Expert Opinion on Pharmacotherapy, 2016, v. 17, n. 14, p. 1881, doi. 10.1080/14656566.2016.1219339
- By:
- Publication type:
- Article
12
Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome–positive chronic myeloid leukemia in chronic phase.
- Published in:
- Expert Opinion on Pharmacotherapy, 2016, v. 17, n. 14, p. 1851, doi. 10.1080/14656566.2016.1219338
- By:
- Publication type:
- Article
13
Advances in dopamine receptor agonists for the treatment of Parkinson’s disease.
- Published in:
- Expert Opinion on Pharmacotherapy, 2016, v. 17, n. 14, p. 1889, doi. 10.1080/14656566.2016.1219337
- By:
- Publication type:
- Article
14
Omarigliptin for the treatment of type 2 diabetes mellitus.
- Published in:
- Expert Opinion on Pharmacotherapy, 2016, v. 17, n. 14, p. 1947, doi. 10.1080/14656566.2016.1218472
- By:
- Publication type:
- Article
15
Tuberculosis therapy for 2016 and beyond.
- Published in:
- Expert Opinion on Pharmacotherapy, 2016, v. 17, n. 14, p. 1859, doi. 10.1080/14656566.2016.1215428
- By:
- Publication type:
- Article